β-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507

An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants

Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471

The prevalence of dementia: A quantitative integration of the literature

Jorm, A. F., Korten, A. E., & Henderson, A. S. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02906.x · Cited by 1,301

Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., Fan, W., Kha, H., Zhang, J., Gong, Y., et al. (2001) · Nature Neuroscience · doi:10.1038/85059 · Cited by 1,001

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818

Alcohol-drinking during later life by C57BL/6J mice induces sex- and age-dependent changes in hippocampal and prefrontal cortex expression of glutamate receptors and neuropathology markers

Szumlinski, K. K., Herbert, J. N., Espinoza, B. M., Madory, L. E., & Scudder, S. L. (2023) · Addiction Neuroscience · doi:10.1016/j.addicn.2023.100099 · Cited by 15

The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease

Ling, S., Zhou, J., Rudd, J. A., Hu, Z., & Fang, M. (2011) · The Anatomical Record · doi:10.1002/ar.21425 · Cited by 17

BACE1 Gene Promoter Single-Nucleotide Polymorphisms in Alzheimer’s Disease

Zhou, W., Cai, F., Li, Y., Yang, G., O’Connor, K. D., Holt, R. A., & Song, W. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9381-6 · Cited by 18

Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer’s Disease

Sarajärvi, T., Marttinen, M., Natunen, T., Kauppinen, T., Mäkinen, P. M., Helisalmi, S., Laitinen, M. H., Rauramaa, T. H., Leinonen, V., Petäjä‐Repo, U. E., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150221 · Cited by 17

Tetrahydroxystilbene glucoside improves learning and (or) memory ability of aged rats and may be connected to the APP pathway.

HouYing, YangQidong, ZhouLin, DuXiaoping, Limin, L., Yuan-mei, ZhouZhiwen, & LiZhenguo (2011) · PubMed · doi:10.1139/y11-081 · Cited by 17

Decrease in catalytic capacity of γ-secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease

Svedružić, Ž. M., Popović, K., & Jengić, V. Š. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.06.002 · Cited by 17

Control of Aβ release from human neurons by differentiation status and RET signaling

Scholz, D., Chernyshova, Y., & Leist, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.012 · Cited by 18

Amyloid Precursor Protein and Presenilin Involvement in Cell Signaling

Venezia, V., Nizzari, M., Carlo, P., Corsaro, A., Florio, T., & Russo, C. (2007) · Neurodegenerative Diseases · doi:10.1159/000101834 · Cited by 17

Human Chorionic Gonadotropin Increases β-Cleavage of Amyloid Precursor Protein in SH-SY5Y Cells

Saberi, S., Du, Y. P., Christie, M. J., & Goldsbury, C. S. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9954-3 · Cited by 16

Neuroprotective Effects of Resveratrol by Modifying Cholesterol Metabolism and Aβ Processing in SAMP8 Mice

Sánchez-Melgar, A., Izquierdo-Ramírez, P. J., Griñán‐Ferré, C., Pallàs, M., Martín, M., & Albasanz, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147580 · Cited by 17

¿Existe la enfermedad de Alzheimer en todos los primates? Afección de Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (I)

Tolédano, A., Álvarez, M. I., López-Rodríguez, A. B., Toledano‐Díaz, A., & Fernández, C. I. (2011) · Neurología · doi:10.1016/j.nrl.2011.05.008 · Cited by 16

Fangchinoline alleviates cognitive impairments through enhancing autophagy and mitigating oxidative stress in Alzheimer’s disease models

Yi, L., Luo, M., Wang, M., Dong, Z., & Du, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1288506 · Cited by 15

PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer’s disease

Syeda, T., Foguth, R. M., Llewellyn, E., & Cannon, J. R. (2020) · Toxicology · doi:10.1016/j.tox.2020.152436 · Cited by 15

Structural Analysis of the Simultaneous Activation and Inhibition of γ-Secretase Activity in the Development of Drugs for Alzheimer’s Disease

Svedružić, Ž. M., Vrbnjak, K., Martinović, M., & Miletić, V. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040514 · Cited by 15

Regulation of the lipidation of β-secretase by statins

Parsons, R. B., Farrant, J. K., Price, G. C., Subramaniam, D., & Austen, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350577 · Cited by 15

Regulation of β cleavage of amyloid precursor protein

Wang, J., Lu, R., & Wang, Y.-Z. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0515-1 · Cited by 14

Age‐related modulation of γ‐secretase activity in non‐human primate brains

Nishimura, M., Nakamura, S., Kimura, N., Liu, L., Suzuki, T., & Tooyama, I. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07884.x · Cited by 14

Quetiapine Modulates Conditioned Anxiety and Alternation Behavior in Alzheimer’s Transgenic Mice

Tempier, A., He, J., Zhu, S., Zhang, R., Kong, L., Tan, Q., Luo, H., Kong, J., & Li, X. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310020010 · Cited by 14

Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis

Área-Gómez, E., & Schon, E. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231318 · Cited by 18

The antigen-binding fragment of human gamma immunoglobulin prevents amyloid β-peptide folding into β-sheet to form oligomers

Valls-Comamala, V., Guivernau, B., Bonet, J., Puig, M., Perálvarez‐Marín, A., Palomer, E., Fernàndez‐Busquets, X., Altafaj, X., Tajes, M., Puig‐Pijoan, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17074 · Cited by 13

Long‐term and in vivo assessment of Aβ protein‐induced brain atrophy in a zebrafish model by optical coherence tomography

Lin, Y., Chen, T., Mao, G., Qiu, T. H., Lan, Y., Xiang, X., Huang, J., Huang, J. L., Lu, T. Y., Gan, S., et al. (2020) · Journal of Biophotonics · doi:10.1002/jbio.202000067 · Cited by 14

Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins

Janssen, L., Keppens, C., Deyn, P. P. D., & Dam, D. V. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.027 · Cited by 11

E3 ligase mahogunin (MGRN1) influences amyloid precursor protein maturation and secretion

Benvegnù, S., Wahle, T., & Dotti, C. G. (2017) · Oncotarget · doi:10.18632/oncotarget.20143 · Cited by 11

Age‐related miRNAs dysregulation and abnormal BACE1 expression following Pb exposure in adolescent mice

Wang, R., Wu, Z., Liu, R., Bai, L., Lin, Y., Ba, Y., & Huang, H. (2022) · Environmental Toxicology · doi:10.1002/tox.23536 · Cited by 10

Targeted Analysis of Tears Revealed Specific Altered Metal Homeostasis in Age-Related Macular Degeneration

Valencia, E., García, M., Fernández, B., Pereiro, R., Lobo, L., & González‐Iglesias, H. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.4.10 · Cited by 10

Splice variants of the Alzheimer’s disease beta-secretase, BACE1

Holsinger, R. M. D., Goense, N., Bohorquez, J., & Strappe, P. (2012) · Neurogenetics · doi:10.1007/s10048-012-0348-3 · Cited by 12

Non-human Primate Models of Alzheimer’s Disease

Li, Y., & Gu, B. J. (2023) · Journal of Exploratory Research in Pharmacology · doi:10.14218/jerp.2023.00006 · Cited by 8

Synthesis and evaluation of 11C-labeled naphthalene derivative as a novel non-peptidergic probe for the β-secretase (BACE1) imaging in Alzheimer's disease brain.

Kawai, T., Kawashima, H., Kuge, Y., & Saji, H. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.03.008 · Cited by 7

Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β‐amyloid peptide accumulation in mice

Peng, H., Bukuroshi, P., Durk, M. R., Grootendorst, P. V., Yan, X., Pan, S. R., de Lannoy, I. A. M., & Pang, K. S. (2021) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2297 · Cited by 8

Inhaled Pollutants of the Gero-Exposome and Later-Life Health

Finch, C. E., & Thorwald, M. A. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae107 · Cited by 8

Aging process alters hippocampal and cortical secretase activities of Wistar rats

Bertoldi, K., Cechinel, L. R., Schallenberger, B., de Meireles, L. C. F., Basso, C. G., Lovatel, G. A., Bernardi, L., Lamers, M. L., & Siqueira, I. R. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.066 · Cited by 8

Advancement in Analytical Techniques for Determining the Activity of β-Site Amyloid Precursor Protein Cleaving Enzyme 1

Fan, J., Wei, X., Dong, H. Y., Zhang, Y., Zhou, Y., Xu, M., & Xiao, G. (2022) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2022.2132812 · Cited by 7

BACE1-dependent metabolism of neuregulin 1: Bridging the gap in explaining the occurrence of schizophrenia-like symptoms in Alzheimer's disease with psychosis?

Vincent, B., & Maitra, S. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101988 · Cited by 7

Air Pollution in Diseases of Aging

Finch, C. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813102-2.00003-0 · Cited by 7

Muramyl dipeptide promotes Aβ1-42 oligomer production via the nod2/p-p38 mapk/bace1 signaling pathway in the sh-sy5y cells

Chen, Y., Chan, Y., Chen, W., Li, Y., & Zhang, C.-Y. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.03.112 · Cited by 6

4-O-galloylalbiflorin discovered from Paeonia lactiflora Pall. is a potential β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor

Hu, X., Li, Y.-B., Qi, S., Zhang, Q., Ren, T., Meng, W., & Zhao, Q. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.10.012 · Cited by 7

In vitro characterization of a γ‐secretase radiotracer in mammalian brain

Patel, S., O'Malley, S. S., Connolly, B., Liu, W., Hargreaves, R. J., Sur, C., & Gibson, R. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03525.x · Cited by 7

Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with ferroptosis

Thorwald, M. A., Godoy-Lugo, J. A., Kerstiens, E., Garcia, G., Kim, M., Shemtov, S. J., Silva, J. A., Durra, S., O’Day, P. A., Mack, W. J., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70322 · Cited by 6

Age-Related Changes in the Synaptic Density of Amyloid-β Protein Precursor and Secretases in the Human Cerebral Cortex

Pliássova, A., Canas, P. M., Xavier, A. C., da Silva, B. S., Cunha, R. A., & Agostinho, P. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160213 · Cited by 6

Naturally occurring histological findings and Alzheimer's‐like pathology in the brain of aging African green monkeys ( Chlorocebus sabaeus )

Corey, T. M., Illanes, O., Lawrence, M. S., Perez, S. E., Liddie, S., & Callanan, J. J. (2023) · The Journal of Comparative Neurology · doi:10.1002/cne.25494 · Cited by 6

High-fat diet exacerbates cognitive and metabolic abnormalities in neuronal BACE1 knock-in mice – partial prevention by Fenretinide

Plucińska, K., Mody, N., Dekeryte, R., Shearer, K., Mcilroy, G. D., Delibegović, M., & Platt, B. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1806190 · Cited by 7

Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease

Evin, G. M., & Barakat, A. (2014) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s41056 · Cited by 6

Examination of Longitudinal Alterations in Alzheimer’s Disease-Related Neurogenesis in an APP/PS1 Transgenic Mouse Model, and the Effects of P33, a Putative Neuroprotective Agent Thereon

Szögi, T., Borbély, E., Schuster, I., Bozsó, Z., Sántha, M., Tóth, M. E., Penke, B., & Fülöp, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810364 · Cited by 6

The Binding of Different Substrate Molecules at the Docking Site and the Active Site of γ-Secretase Can Trigger Toxic Events in Sporadic and Familial Alzheimer’s Disease

Svedružić, Ž. M., Jengić, V. Š., & Ostojić, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031835 · Cited by 5

Protein Aggregation Disorders

Outeiro, T. F., McLean, P. J., & Hyman, B. T. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50012-8 · Cited by 5

Noninvasive Assessment of β‐Secretase Activity Through Click Chemistry‐Mediated Enrichment of Neuronal Extracellular Vesicles to Detect Alzheimer's Disease

Kim, H. Y., Lee, J., Qian, A., Ji, Y., Zhang, R., Hu, Q., Williams, C. K., Chuang, H., Smalley, M. D., Xu, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202415289 · Cited by 4

A tale of two pathways: Regulation of proteostasis by UPRmt and MDPs

Johns, A., Higuchi‐Sanabria, R., Thorwald, M. A., & Vı́lchez, D. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102673 · Cited by 4

Nicotinic acetylcholine receptor activation induces BACE1 transcription via the phosphorylation and stabilization of nuclear SP1

Nakano, M., Tsuchida, T., Mitsuishi, Y., & Nishimura, M. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.12.002 · Cited by 4

Neuronal aging potentiates beta-amyloid generation via amyloid precursor protein endocytosisPreprint

Burrinha, T., Gomes, R. A., Terrasso, A. P., & Almeida, C. G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/616540 · Cited by 4

Amyloidogenic proteolysis of APP regulates glutamatergic presynaptic functionPreprint

Kapadia, A., Schuhmann, F., Daşkın, E., Walter, J., Lindahl, I., Rahmani, N., Pezeshkian, W., & Hafner, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.01.667924 · Cited by 4

Effects of Exercise Training and L-Arginine Loaded Chitosan Nanoparticles on Hippocampus Histopathology, β-Secretase Enzyme Function, APP, Tau, Iba1and APOE-4 mRNA in Aging Rats

Feizolahi, F., Arabzadeh, E., Sarshin, A., Falahi, F., Dehghannayeri, Z., Askari, A. A., Wong, A., Aghaei, F., & Zargani, M. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00699-y · Cited by 3

Age-Associated Calcification: Insights from Murine Models

Nasi, S., Romani, M., & Busso, N. (2024) · Gout Urate and Crystal Deposition Disease · doi:10.3390/gucdd2030018 · Cited by 3

Plasma Amyloid Is Associated with White Matter and Subcortical Alterations and Is Modulated by Age and Seasonal Rhythms in Mouse Lemur Primates

Gary, C., Hérard, A., Hanss, Z., & Dhénain, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00035 · Cited by 3

Effects of Granulocyte–Macrophage Colony-Stimulating Factor on Neuronal Senescence in Ultraviolet Irradiated Skin

Moon, K., Lee, H.-S., Son, S. T., Lee, J. S., Dhong, E., Jeong, S., & Han, S. (2019) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000005183 · Cited by 3

Apolipoproteins in Different Amyloidoses

Sadowski, M., & Wısnıewskı, T. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_6 · Cited by 3

Amyloid and tau pathologies cross-talk to promote Alzheimeŕs disease: novel mechanistic insights

Ávila, J., Hernández, F., & Perry, G. L. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.07.025 · Cited by 3

BET protein inhibitor JQ1 reduces inflammation and hippocampal amyloid-β level without altering Tau phosphorylation in LPS-challenged adult wild-type mice

Matuszewska, M., Cieślik, M., Sulejczak, D., Wilkaniec, A., & Czapski, G. A. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150318 · Cited by 2

Increase of brain Aβ peptides and secretase activity during normal aging in rodent and human

Godoy-Lugo, J. A., Thorwald, M. A., Head, E., Gomm, A., Zhang, C., Tanzi, R. E., & Finch, C. E. (2025) · GeroScience · doi:10.1007/s11357-025-01926-w · Cited by 2

Resveratrol induces molecular changes in cholesterol homeostasis in SAMP8 mice cerebellum

Tejero, A., Benito-Patón, V., Griñán‐Ferré, C., Pallàs, M., León-Navarro, D., & Martín, M. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119319 · Cited by 2

In silico Test Proteolytic Potential of Papain and Zingibain Enzymes Against Protein Forming Congenital and Senilis Cataracts

Damai, G. L., Cahyana, N. W., & Aziz, A. M. (2022) · Journal of Agromedicine and Medical Sciences · doi:10.19184/ams.v8i1.23324 · Cited by 2

GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects

Park, H., Kwon, H. S., Lee, K., Kim, Y. E., Son, J., Choi, N.-Y., Han, M., Park, D. W., Kim, S., & Koh, S. (2024) · Aging · doi:10.18632/aging.205489 · Cited by 3

The association of three BACE1 gene polymorphisms (exon5 C/G, intron 5 T/G and 3'UTR T/A) with sporadic Alzheimer's disease susceptibility: a meta-analysis.

Yuan, H. D., Ling, K., Du, X., Ge, P., Wu, S., & Wang, X. (2015) · Europe PMC (PubMed Central) · Cited by 2

Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology

Thomas, R. S., Alsaqati, M., Bice, J. S., Hvoslef‐Eide, M., Good, M. A., & Kidd, E. J. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000861 · Cited by 2

Secretase Processing of Amyloid Precursor Protein (APP) and Neurodegeneration

Marks, N., & Berg, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_16 · Cited by 2

Alzheimer's Disease BACE Proteases

Roßner, S., & Lichtenthaler, S. F. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_11 · Cited by 1

Presynaptic accumulation of APP-CTFβ may contribute to synaptic dysfunction in Alzheimer’s disease

Kapadia, A., Schuhmann, F., Daşkın, E., Walter, J., Lindahl, I., Rahmani, N., Morrema, T. H. J., Rozemüller, A. J. M., Boon, B. D. C., Pezeshkian, W., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00899-6 · Cited by 1

BRAIN SENESCENCE-OMICS

Chakrabarti, A., & Mukhopadhyay, D. (2013) · Journal of Proteins and Proteomics · Cited by 1

Frontiers in Clinical Drug Research - Alzheimer Disorders

Atta-ur-rahman, Mavoungou, C., Zimmerman, K. S., Wright, J., Harding, J., Cavallaro, R., Fuso, A., Yoshiyama, Y., Asija, Z., Clifford, A., et al. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97816810806801150301 · Cited by 1

Biochemical changes precede affective and cognitive anomalies in aging adult C57BL/6J mice with a prior history of adolescent alcohol binge‐drinking

Chavez, C. L. J., Scheldrup, G. P., Madory, L. E., Denning, C. J. E., Lee, E. C., Nguyen, D. T., Castro, M., Garcia, A., Torres-Gonzalez, J., Herbert, J. N., et al. (2024) · Addiction Biology · doi:10.1111/adb.70006 · Cited by 2

Neuron-Astrocyte Interactions in Aging and Alzheimer's Disease: Dysregulation of Amyloid Precursor Protein

Jáuregui, G. V., & Parpura, V. (2025) · Ageing & Longevity · doi:10.47855/jal9020-2025-2-3 · Cited by 1

Brain geometry matters in Alzheimer’s disease progression: a simulation studyPreprint

Hoore, M., Kelling, J., Sayadmanesh, M., Mitra, T., Schips, M., & Meyer‐Hermann, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.24.220228 · Cited by 1

Identification of a BACE dimer and characterization of its biochemical and enzymatic properties

Westmeyer, G. G. (2006) · doi:10.5282/edoc.5969

Implications of cholesterol and cholesterol-lowering therapy in Alzheimer s disease

Famer, D. (2007) · Figshare

Amyloid precursor protein: cellular studies and animal models

Nilsson, T. (2006) · Figshare

Quetiapine modulates anxiety-like behaviours and alleviates the decrease of BDNF in the amygdala of an APP/PS1 transgenic mouse model of Alzheimer’s disease

Tempier, A. (2009) · University Library - University of Saskatchewan (University of Saskatchewan)

Modulation of BACE1 by a novel sorting nexin in Alzheimer's disease

Okada, H. (n.d.) · ProQuest Demo Repository

Molecular changes during the development of Alzheimer's disease

Wirz, K. T. S. (2013) · Data Archiving and Networked Services (DANS)

Genetic and Expressional Studies of Alzheimer's Disease

Iivonen, S. (2005)

Der Einfluss des Geschlechts auf die Neuronenanzahl in einem APP/PS1- doppeltransgenen Mausmodell der Alzheimer-Krankheit

Neurobiologie, A. F. (2006)

CELLULAR STUDIES AND ANIMAL MODELS

Nilsson, T. (2006)

Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease Marta PeraDaniel AlcoleaRaquel Sanchez-ValleCristina Guardia-LaguartaMartõ´ Colom-Cadena • Nahuai BadiolaMarc Suarez-CalvetAlbert Llado ´ • Alvaro A. Barrera-OcampoDiego Sepulveda-Falla • Rafael BlesaJoseL. MolinuevoJordi ClarimonIsidre FerrerEllen GelpiAlberto Lleo ´

Ferrer, I., & Gelpí, E. (2013)

JB Minireview—Membrane Traffic in Physiology and Pathology Trafficking of Alzheimer’s Disease–Related Membrane Proteins and Its Participation in Disease Pathogenesis

Suzuki, T., Araki, Y., Yamamoto, T., & Nakaya, T. (2006)

Localization of secretases involved in the processing of β- Amyloid precursor protein related to alzheimer’s disease

Pliássova, A. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

de dans la maladie d'Alzheimer

Sévalle, J. (2009)

The role of APP and its homologous proteins in synaptic function and plasticity

Kilian, B. S. (2008) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-200906220200-9

Beneficial effects of quetiapine in the APP/PS1 transgenic mice: implications for early intervention for Alzheimer's disease

Zhu, S. (2011) · Mspace (University of Manitoba)

Structural Analysis of Simultaneous Activation and Inhibition of γ-Secretase Activity in Development of Drugs for Alzheimer’s diseasePreprint

Svedružić, Ž. M., Vrbnjak, K., Martinović, M., & Miletić, V. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.22.307959

ADAM10 pharmacological inhibition modifies the expression of components of the dopaminergic systemPreprint

Maitra, S., & Vincent, B. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.26.493662

Role of Enzymes in Alzheimer’s Disease

Patel, S., Shrivastava, S., Marar, P. V., Swami, R., & Jeengar, M. K. (2024) · Springer eBooks · doi:10.1007/978-981-97-6822-6_2

Amyloid fibrils in Alzheimer's disease differently modulate sleep and cortical oscillations in mice depending on the type of amyloid

Sanagi, T., Okumura, M., Lin, Y., Kanemura, S., Moon, E., Heo, Y., Takahara, K., Lee, Y.-H., & Tsunematsu, T. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107599

Etude d’une cible thérapeutique pour la maladie d’Alzheimer et mise au point de nouveaux modèles cellulaires de criblage

Dorard, E. (2016) · theses.fr (ABES) · doi:10.70675/ac92541dza507z4e51z905dz0fe104164d51

Computational fragment-based design of chemically modified oligonucleotides for selective protein inhibition : BACE1 as a case study

González‐Alemán, R. (2023) · theses.fr (ABES) · doi:10.70675/d579a173zeee9z409fzaf5ez64ae20859f75

Contribution à l'étude des facteurs de risque pour la maladie d'Alzheimer : analyse de candidats identifiés par étude d'association pangénomique ou GWAS

Bauer, C. (2023) · theses.fr (ABES) · doi:10.70675/0d82043ezd7c7z4fb4z9fc8ze2d05d18b02b

Age-related modulation of γ-secretase activity in non-human primate brains.

西村, 正., 中村, 紳., 遠山, 育., NISHIMURA, M., NAKAMURA, S., Kimura, N., Lei, L. I. U., Suzuki, T., & Tooyama, I. (n.d.) · Institutional Repositories DataBase (IRDB)

Microbes and Microbial Chemical Matter in the Seeding of Alzheimer’s Disease: Prospects for Orthogonal Therapies

Kumar, N., & Yarlagadda, V. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00255

In Vitro Screening of Sargassum spp. Ethanolic Extracts for Antioxidant Activity and Inhibition of Disease-Associated Enzymatic Targets Related to Diabetes, Alzheimer’s Disease, and Parkinson’s Disease

Ali, M. Y., Park, S. E., Jung, H., & Choi, J. S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198643

BindingDB Entry 50031480: Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.

BindingDB (2010) · UC San Diego · doi:10.7270/q20z73dj

P2‐093: Age‐related modulation of gamma‐secretase activity in monkey brains

Nishimura, M., Nakamura, S., Kimura, N., Suzuki, T., & Tooyama, I. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.797

Increase of brain Aβ peptides and secretase activity during normal aging in rodent and human

Godoy-Lugo, J. A., Thorwald, M. A., Head, E., Gomm, A., Zhang, C., Tanzi, R. E., & Finch, C. E. (2025) · GeroScience · doi:10.1007/s11357-025-01926-w · Cited by 2

Age-related modulation of γ-secretase activity in non-human primate brains.

西村, 正., 中村, 紳., 遠山, 育., NISHIMURA, M., NAKAMURA, S., Kimura, N., Lei, L. I. U., Suzuki, T., & Tooyama, I. (n.d.) · Institutional Repositories DataBase (IRDB)

Changes with Age in the Activities of β‐Secretase and the Aβ‐Degrading Enzymes Neprilysin, Insulin‐Degrading Enzyme and Angiotensin‐Converting Enzyme

Miners, J. S., Helmond, Z. V., Kehoe, P. G., & Love, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00375.x · Cited by 80

Changes in β‐secretase activity and regulation in aging and disease

Holler, C. J., Webb, R. L., Ahmed, R. R., Li, F., Beckett, T. L., & Murphy, M. P. (2009) · The FASEB Journal · doi:10.1096/fasebj.23.1_supplement.671.8